| Code | Headline | Release Date |
|---|---|---|
VTL |
40760 NSX Company Name Change Notification - Change of Company Name VGI Health Technology Limited - Change of Company Name to Invictus Therapeutics Ltd |
01-Dec-2025 4:14:37 PM |
VTLPrice Sensitive |
40325 NSX Capital Reconstruction - Share Consolidation Notice of Share Consolidation |
28-Nov-2025 1:55:40 PM |
VTLPrice Sensitive |
40930 NSX Results of Meeting - Results of 2025 AGM VGI Health Technology Limited - results of 2025 AGM |
28-Nov-2025 12:54:13 PM |
VTL |
40130 NSX Ceasing to be a Substantial Shareholder - Form 605 Notice of Ceasing to be a Substantial Holder |
28-Oct-2025 9:25:10 AM |
VTL |
40910 NSX Notice of Annual General Meeting - 2025 Annual General Meeting 2025 Notice of Annual General Meeting and Proxy Form |
27-Oct-2025 9:13:59 AM |
VTL |
41999 NSX General Market Disclosure Other - Expiry of Unlisted Options VGI Health Technology Limited - Expiry of Unlisted Options |
23-Oct-2025 9:35:57 AM |
VTLPrice Sensitive |
40510 NSX Annual Report - Annual Report 30 june 2025 VGI Health Technology Limited - Annual Report for the period ended 30 June 2025 |
17-Oct-2025 3:52:06 PM |
VTLPrice Sensitive |
40540 NSX Half Yearly Report - Half Year Report 31 December 2024 VGI Health Technology Limited - Interim Report for the period ended 31 December 2024 |
17-Oct-2025 3:51:54 PM |
VTL |
40050 NSX Suspension from Official Quotation - Continuous Suspension from Official Quotation Failure to lodge Annual Financials for 30 June 2025 |
03-Oct-2025 10:03:44 AM |
VTL |
40050 NSX Suspension from Official Quotation - Continuous Suspension from Official Quotation Continuous Suspension from Official Quotation - Failure to lodge Preliminary Financials for 30 June 2025 |
17-Sep-2025 9:50:15 AM |
VTL |
40050 NSX Suspension from Official Quotation - Continuous Suspension from Official Quotation - Non-payment of 2025-26 Annual Listing Fees Continuous Suspension from Official Quotation - Non-payment of 2025-26 Annual Listing Fees |
19-Aug-2025 4:17:56 PM |
VTLPrice Sensitive |
41999 NSX General Market Disclosure Other - Capital Raising and Delisting Update 14 August 2025 Capital Raising and Delisting Update 14 August 2025 |
14-Aug-2025 2:37:14 PM |
VTL |
41999 NSX General Market Disclosure Other - Expiry of Unlisted Options Expiry of Unlisted Options |
29-Jul-2025 9:04:43 AM |
VTL |
40750 NSX Details of Share Registry - Change of Registry Address Notification Change of Registry Address Notification |
14-Apr-2025 11:12:55 AM |
VTL |
40050 NSX Suspension from Official Quotation - Suspension from Official Quotation Suspension from Official Quotation - Failure to lodge Half Yearly Financials for 30 June 2024 |
21-Mar-2025 9:41:01 AM |
VTLPrice Sensitive |
40030 NSX Trading Halt - Trading Halt Failure To Lodge Half Yearly Financials Trading Halt Failure To Lodge Half Yearly Financials |
19-Mar-2025 10:11:41 AM |
VTLPrice Sensitive |
40560 NSX Quarterly Report - Quarterly Report Quarterly Report for the period ending 31 December 2024 |
03-Feb-2025 9:13:17 AM |
VTL |
40930 NSX Results of Meeting - Results of 2024 AGM VGI Health Technology Limited - results of 2024 AGM |
26-Nov-2024 11:00:22 AM |
VTLPrice Sensitive |
40560 NSX Quarterly Report - Quarterly Report for September 2024 Quarterly Report for the period ending 30 September 2024 |
30-Oct-2024 4:40:37 PM |
VTL |
40910 NSX Notice of Annual General Meeting - 2024 Annual General Meeting Notice of Meeting and proxy form for 2024 Annual General Meeting |
21-Oct-2024 12:11:58 PM |
VTLPrice Sensitive |
40051 NSX Reinstatement to Official Quotation - Reinstatement to Official Quotation Reinstatement to Official Quotation |
04-Oct-2024 4:19:36 PM |
VTLPrice Sensitive |
40510 NSX Annual Report - 2024 Annual Report VGI Health Technology Limited Annual Report for the year ended 30 June 2024 |
27-Sep-2024 2:54:21 PM |
VTLPrice Sensitive |
40050 NSX Suspension from Official Quotation - Suspension from Official Quotation - Failure to lodge Preliminary Final Report - 13/09/2024 Suspension from Official Quotation - Failure to lodge Preliminary Final Report - Due 13/09/2024 |
18-Sep-2024 9:45:58 AM |
VTLPrice Sensitive |
41999 NSX General Market Disclosure Other - Settlement of Dispute VGI executes Deed of Settlement and Agreement with Cornwalls |
17-Sep-2024 9:09:47 AM |
VTLPrice Sensitive |
40599 NSX Periodic Disclosure Other - Financial Reporting FY24 Update Financial Reporting FY24 Update |
16-Sep-2024 11:54:24 AM |
VTLPrice Sensitive |
40030 NSX Trading Halt - Trading Halt Trading Halt |
16-Sep-2024 10:03:43 AM |
VTLPrice Sensitive |
40030 NSX Trading Halt - Trading Halt Trading Halt |
16-Sep-2024 10:04:01 AM |
VTLPrice Sensitive |
41999 NSX General Market Disclosure Other - Creditor's Statutory Demand VGI Health Technology Limited served with creditor's statutory demand from Cornwalls Lawyers Melbourne |
15-Aug-2024 9:29:22 AM |
VTLPrice Sensitive |
40140 NSX Section 205G Notice Initial/Final Director's Interests - Final Director's Interest Notice Final Director's Interest Notice - Richard Estalella |
12-Aug-2024 4:37:40 PM |
VTL |
40140 NSX Section 205G Notice Initial/Final Director's Interests - Initial Director's Interest Initial Director's Interest - Johnathan Wong |
12-Aug-2024 4:35:39 PM |
VTLPrice Sensitive |
40023 NSX Director's Declaration & Undertaking - Director's Declaration and Undertaking Director's Declaration and Undertaking for Johnathan Wong |
12-Aug-2024 4:37:56 PM |
VTL |
40810 NSX Director Appointment/Resignation - Board Changes VGI Health Technology Limited - Board Changes |
12-Aug-2024 4:35:51 PM |
VTLPrice Sensitive |
40560 NSX Quarterly Report - Quarterly Report June 2024 Quarterly Report |
31-Jul-2024 1:00:02 PM |
VTLPrice Sensitive |
40560 NSX Quarterly Report - Quarterly Report March '24 Quarterly Report |
22-Apr-2024 1:30:49 PM |
VTLPrice Sensitive |
40023 NSX Director's Declaration & Undertaking - Director's Declaration for Richard Estalella NSX Director's Declaration & Undertaking for Richard Estalella |
23-Feb-2024 9:28:37 AM |
VTLPrice Sensitive |
41999 NSX General Market Disclosure Other - VTL - New Partnership VGI Health Technology Limited - non-binding Heads of Agreement |
14-Feb-2024 3:08:55 PM |
VTL |
40140 NSX Section 205G Notice Initial/Final Director's Interests - Final Director's Notice Final Director's Notice - Lou Panaccio |
14-Feb-2024 10:31:07 AM |
VTL |
40140 NSX Section 205G Notice Initial/Final Director's Interests - Initial Director's Notice Initial Director's Notice - Richard Estalella |
14-Feb-2024 10:30:53 AM |
VTL |
40810 NSX Director Appointment/Resignation - Board Changes VGI Health Technology Limited -Board Changes |
14-Feb-2024 10:30:15 AM |
VTLPrice Sensitive |
40550 NSX Half Yearly Report Audit Review - Half Year Report Interim Report for the Half Year ended 31 December 2023 |
08-Feb-2024 4:52:22 PM |
VTLPrice Sensitive |
40560 NSX Quarterly Report - Dec '23 Quarterly Report VGI Health Technology Limited December 2023 Quarterly Report |
23-Jan-2024 3:05:40 PM |
VTLPrice Sensitive |
41999 NSX General Market Disclosure Other - HREC Approval for Phase II Clinical Study HREC Approval for Pancreatic Cancer Phase II Clinical Study |
11-Jan-2024 9:04:52 AM |
VTL |
40930 NSX Results of Meeting - Results of 2023 AGM Results of 2023 Annual General Meeting |
04-Dec-2023 1:31:26 PM |
VTL |
40910 NSX Notice of Annual General Meeting - 2022023 Annual General Meeting 2023 Notice of Annual General Meeting |
25-Oct-2023 5:02:48 PM |
VTLPrice Sensitive |
40560 NSX Quarterly Report - Quarterly Report Quarterly Report for September 2023 |
25-Oct-2023 9:19:52 AM |
VTL |
40024 NSX Nominated Adviser's Declaration - Nominated Adviser's Declaration - Dash Corporate Lawyers Pty Ltd Nominated Adviser's Declaration - Dash Corporate Lawyers Pty Ltd |
02-Oct-2023 10:47:34 AM |
VTL |
40510 NSX Annual Report - 2023 Annual Report Annual Report for the year ended 30 June 2023 |
07-Sep-2023 8:34:14 AM |
VTL |
40499 NSX Assets Other - VTL commences divestment of Invictus BioPharma Pty Ltd VGI Health Technology Limited commences divestment of Invictus BioPharma Pty Ltd |
29-Aug-2023 11:16:31 AM |
VTL |
40599 NSX Periodic Disclosure Other - Annual Nominated Adviser Statement for 2023 - 2024 Annual Nominated Adviser Statement for 2023 - 2024 |
11-Aug-2023 2:49:51 PM |
VTLPrice Sensitive |
40560 NSX Quarterly Report - Quarterly Report Quarterly Report - 30 June 2023 |
28-Jul-2023 9:50:28 AM |
VTLPrice Sensitive |
41999 NSX General Market Disclosure Other - New R & D Loan VTL enters into new R & D Loan Facility with TIV Holdings Pty Ltd |
29-Jun-2023 10:55:20 AM |
VTL |
40730 NSX Details of Registered Office - Change of Registered Address VGI Health Technology Limited - Change of Registered Office |
26-Jun-2023 9:52:38 AM |
VTL |
41999 NSX General Market Disclosure Other - Extension of Sunset Date VGI Health Technology Limited further updates Sunset Date for sale of Invictus BioPharma Pty Ltd |
26-Jun-2023 9:52:24 AM |
VTLPrice Sensitive |
40560 NSX Quarterly Report - Quarterly Report NSX Quarterly Report for the period ending 31 March 2023 |
19-Apr-2023 1:01:18 PM |
VTL |
41999 NSX General Market Disclosure Other - Extension of Sunset Date VGI Health Technology Limited further updates Sunset Date for sale of Invictus BioPharma Pty Ltd |
03-Apr-2023 3:40:31 PM |
VTLPrice Sensitive |
40540 NSX Half Yearly Report - Interim Report Interim Report for the half year ended 31 December 2022 |
16-Feb-2023 3:25:01 PM |
VTL |
40599 NSX Periodic Disclosure Other - Quarterly Update Dec '22 Quarterly Update |
31-Jan-2023 8:42:55 AM |
VTLPrice Sensitive |
40560 NSX Quarterly Report - Quarterly Report - 31 December 2022 Quarterly Report - 31 December 2022 |
31-Jan-2023 8:42:36 AM |
VTLPrice Sensitive |
41999 NSX General Market Disclosure Other - Update on sale of IVB VGI Health Technology Limited further updates Sunset Date for sale of Invictus BioPharma Pty Ltd |
21-Dec-2022 4:05:24 PM |
VTL |
40730 NSX Details of Registered Office - Company Update Company Update |
21-Dec-2022 12:04:54 PM |
VTL |
41999 NSX General Market Disclosure Other - Update on NAFLD/NASH Phase II Clinical Study VGI Health Technology Limited - Update on NAFLD/NASH Phase II Clinical Study |
19-Dec-2022 9:04:34 AM |
VTL |
40930 NSX Results of Meeting - 2022 AGM Results Results of 2022 Annual General Meeting |
30-Nov-2022 12:01:42 PM |
VTLPrice Sensitive |
40499 NSX Assets Other - Extension of Sunset Date Extension of Sunset Date for sale of Invictus BioPharma Pty Ltd |
29-Nov-2022 9:03:18 AM |
VTLPrice Sensitive |
40499 NSX Assets Other - Update on sale of IVB Update to sunset date for sale of subsidiary Invictus Biopharma Pty Ltd |
25-Oct-2022 4:08:20 PM |
VTL |
40940 NSX Proxy Form - 2022 AGM Proxy Form VGI Health Technology Limited Proxy Form for 2022 Annual General Meeting |
25-Oct-2022 8:55:19 AM |
VTL |
40910 NSX Notice of Annual General Meeting - 2022 Annual General Meeting VGI Health Technology Limited 2022 Annual General Meeting |
25-Oct-2022 8:55:02 AM |
VTLPrice Sensitive |
40599 NSX Periodic Disclosure Other - Sept 2022 Quarterly Update VGI Health Technology - Sept 2022 Quarterly Update |
19-Oct-2022 12:00:20 PM |
VTLPrice Sensitive |
40560 NSX Quarterly Report - Sept 2022 Quarterly Report VGI Health Technology Limited - Sept Quarterly Report |
19-Oct-2022 12:00:00 PM |
VTLPrice Sensitive |
41999 NSX General Market Disclosure Other - Extension of Convertible Note Facility Term VGI Health Technology extends term of convertible note facility |
14-Oct-2022 2:50:01 PM |
VTLPrice Sensitive |
41999 NSX General Market Disclosure Other - R & D Facility Agreement with Fundsquire Pty Ltd VGI Health Technology Limited enters into R & D Loan Facility Agreement with Fundsquire Pty Ltd |
13-Oct-2022 3:26:00 PM |
VTLPrice Sensitive |
41999 NSX General Market Disclosure Other - NAFLD/NASH Phase II Clinical Study NAFLD/NASH Phase II Clinical Study commences dosing patients |
05-Oct-2022 8:58:47 AM |
VTLPrice Sensitive |
41999 NSX General Market Disclosure Other - Ethics approval received for US Clinical Study Ethics Approval Received for US Pharmacokinetics and Exercise Clinical Study |
26-Sep-2022 8:54:56 AM |
VTLPrice Sensitive |
41999 NSX General Market Disclosure Other - NAFLD/NASH PhaseII Clinical Study Recruits 1st Patient NAFLD/NASH Phase II Clinical Study Recruits 1st Patient |
14-Sep-2022 8:50:58 AM |
VTLPrice Sensitive |
40420 NSX Asset Disposal - Updated Invictus BioPharma Group sale date Updated Invictus BioPharma Group sale date |
08-Sep-2022 9:16:02 AM |
VTL |
40599 NSX Periodic Disclosure Other - Annual Nominated Adviser Statement for 2022 - 2023 Annual Nominated Adviser Statement for 2022 - 2023 |
05-Sep-2022 10:37:25 AM |
VTLPrice Sensitive |
40510 NSX Annual Report - 2022 Annual Report Annual Report for the year ended 30 June 2022 |
10-Aug-2022 11:10:00 AM |
VTLPrice Sensitive |
40560 NSX Quarterly Report - June 2022 Quarterly Report VGI Health Technology - June 2022 Quarterly Report |
29-Jul-2022 8:58:05 AM |
VTL |
40599 NSX Periodic Disclosure Other - June 2022 Quarterly Update VGI Health Technology - June 2022 Quarterly Update |
29-Jul-2022 8:57:48 AM |
VTL |
41999 NSX General Market Disclosure Other - Clinical Study begins recruitment of patients NAFLD/NASH Phase II Clinical Study begins recruitment of patients |
05-Jul-2022 9:29:44 AM |
VTLPrice Sensitive |
40081 NSX Response to Query - VTL Response to NSX Price Query - 29 June 2022 VTL Response to NSX Price Query - 29 June 2022 |
30-Jun-2022 11:40:02 AM |
VTLPrice Sensitive |
40080 NSX Query - Price Query NSX Price Query to VTL - 29 June 2022 |
30-Jun-2022 11:39:58 AM |
VTLPrice Sensitive |
40930 NSX Results of Meeting - Results of SGM Results of Special General Meeting held 3 June 2022 |
03-Jun-2022 12:42:27 PM |
VTLPrice Sensitive |
40920 NSX Notice of Extraordinary Meeting - Notice of Meeting Extraordinary General Meeting of Shareholders |
02-May-2022 5:05:57 PM |
VTLPrice Sensitive |
40560 NSX Quarterly Report - Quarterly report for the period ending 31 March 2022 Quarterly report for the period ending 31 March 2022 |
29-Apr-2022 2:40:34 PM |
VTL |
40599 NSX Periodic Disclosure Other - Quarterly Update Update for the period ending 31 March 2022 |
29-Apr-2022 2:40:32 PM |
VTLPrice Sensitive |
40420 NSX Asset Disposal - Binding sale agreement of subsidiary Binding sale agreement of subsidiary |
06-Apr-2022 8:50:31 AM |
VTLPrice Sensitive |
41999 NSX General Market Disclosure Other - US Divisional Patent to be granted US Divisional Patent to be granted |
04-Apr-2022 7:44:06 AM |
VTLPrice Sensitive |
41999 NSX General Market Disclosure Other - VTL to present at American Society for Nutrition Conf. VTL to present at American Society for Nutrition Conference |
21-Mar-2022 8:57:21 AM |
VTLPrice Sensitive |
40550 NSX Half Yearly Report Audit Review - Half Year Report 31 December 2021 Half Year Audit Reviewed Financial Statements |
11-Mar-2022 1:30:24 PM |
VTL |
40460 NSX Agreement Notice - VTL Executes Agreement with Continuum Sciences LLC VGI Health Technology executes Sales Representative Agreement with Continuum Sciences LLC |
25-Feb-2022 9:02:59 AM |
VTL |
41999 NSX General Market Disclosure Other - Dr Moon to present at Experimental Biology Conference VTL's Dr Jordan Moon to present at Experimental Biology Conference in Philadelphia |
23-Feb-2022 8:36:29 AM |
VTLPrice Sensitive |
40420 NSX Asset Disposal - Term Sheet for Sale of Invictus BioPharma Group VGI Health Technology executes Term Sheet for sale of the Invictus BioPharma Group |
14-Feb-2022 9:09:10 AM |
VTL |
41999 NSX General Market Disclosure Other - Approval of new clinical study site Approval for new NAFLD/NASH Phase II clinical study site at the Gallipoli Medical Research Foundation in Queensland |
09-Feb-2022 9:05:22 AM |
VTL |
40470 NSX Patent Notice - Hong Kong Patent Granted Hong Kong Patent Granted to VTL subsidiary Invictus Biotechnology Pty Ltd |
08-Feb-2022 8:57:15 AM |
VTLPrice Sensitive |
40560 NSX Quarterly Report - Quarterly update VGI Health Dec '21 Quarterly Cashflow Report |
27-Jan-2022 9:05:54 AM |
VTL |
40460 NSX Agreement Notice - Contract with Resonance Health VTL contracts with Resonance Health for its NASH Phase II Clinical Study |
25-Jan-2022 8:42:04 AM |
VTLPrice Sensitive |
41999 NSX General Market Disclosure Other - Nutraceutical products listed on Amazon VGI Health Technology's NE1-Elite® and NE1-Heart® nutraceutical products listed on Amazon |
20-Jan-2022 9:05:26 AM |
VTL |
40599 NSX Periodic Disclosure Other - Quarterly update Quarterly update for December '21 quarter |
19-Jan-2022 10:08:43 AM |
VTLPrice Sensitive |
40470 NSX Patent Notice - Patent application lodged PCT Patent Application for Transmucosal Delivery of Tocotrienols lodged |
07-Dec-2021 9:14:36 AM |
VTLPrice Sensitive |
40460 NSX Agreement Notice - VGI Health Technology partners with ENDRA Life Sciences in NAFLD/NASH Phase II Clinical Study VGI Health Technology partners with ENDRA Life Sciences in NAFLD/NASH Phase II Clinical Study |
29-Nov-2021 8:15:51 AM |
VTL |
40930 NSX Results of Meeting - 2021 AGM Results VTL announces results of 2021 Annual General Meeting |
17-Nov-2021 11:35:58 AM |
VTLPrice Sensitive |
40560 NSX Quarterly Report - September 2021 Quarterly Report VTL September 2021 Quarterly Cashflow Report |
29-Oct-2021 8:34:01 AM |
VTLPrice Sensitive |
40470 NSX Patent Notice - Japanese Patent to be granted Japanese patent to be granted for Transmucosal Delivery of Tocotrienols |
18-Oct-2021 11:58:18 AM |
VTLPrice Sensitive |
40560 NSX Quarterly Report - Quarterly update September 2021 Quarterly Update |
08-Oct-2021 8:53:18 AM |
VTLPrice Sensitive |
41999 NSX General Market Disclosure Other - HREC Approval from RMH HREC Approval received from The Royal Melbourne Hospital for NAFLD/NASH study |
06-Oct-2021 9:33:47 AM |
VTLPrice Sensitive |
40799 NSX Details Other - Draw Down of Convertible Note Facility VTL draws down on $1.5M convertible loan facility with Cornerstone Investor |
05-Oct-2021 4:06:48 PM |
VTL |
41999 NSX General Market Disclosure Other - Correction announcement Correction to announcement about the release of the 2021 Annual Report to Shareholders |
22-Sep-2021 4:05:55 PM |
VTLPrice Sensitive |
40510 NSX Annual Report - FY21 Annual Report issued to Shareholders VGI Health Technology issues 2021 Annual Report to Shareholders |
22-Sep-2021 10:36:00 AM |
VTL |
40910 NSX Notice of Annual General Meeting - 2021 Annual General Meeting Notice of Annual General Meeting and Proxy Form |
22-Sep-2021 10:35:56 AM |
VTL |
41999 NSX General Market Disclosure Other - Appointment of Professor Crawford to SAB VTL appoints Professor Darrell Crawford to Scientific Advisory Board |
15-Sep-2021 10:12:36 AM |
VTL |
41999 NSX General Market Disclosure Other - Appointment of Clinical Study Site VTL appoints Gallipoli Medical Research Foundation as NAFLD/NASH Clinical Study Site |
14-Sep-2021 9:56:38 AM |
VTL |
41999 NSX General Market Disclosure Other - Study protocol approved VTL approves study protocol for NE1-Elite® clinical study in US |
13-Sep-2021 9:39:57 AM |
VTLPrice Sensitive |
40510 NSX Annual Report - 2021 Statutory Financial Statements 2021 Statutory Financial Statements |
08-Sep-2021 8:00:51 AM |
VTLPrice Sensitive |
41999 NSX General Market Disclosure Other - Renewal of R & D Receivable Facility VGI Health Technology renews R & D Receivables Facility with FIFO Capital for FY22 |
07-Sep-2021 9:12:09 AM |
VTL |
41999 NSX General Market Disclosure Other - Certification of NE1-Elite® VGI Health Technology's NE1-Elite® sports nutraceutical product certified by Informed Sport |
12-Aug-2021 9:30:45 AM |
VTLPrice Sensitive |
40560 NSX Quarterly Report - June 2021 Quarterly Report June 2021 Quarterly Report |
30-Jul-2021 11:20:19 AM |
VTL |
41999 NSX General Market Disclosure Other - Shareholder update Shareholder and investor update |
13-Jul-2021 1:09:42 PM |
VTL |
40760 NSX Company Name Change Notification - Change of Company Name Change of Company Name |
12-Jul-2021 3:52:54 PM |
VTL |
40022 NSX Articles of Association/Constitution - New Constitution Adoption of new constitution |
09-Jul-2021 11:46:25 AM |
VTL |
40930 NSX Results of Meeting - Results of EGM Results of Extraordinary General Meeting of Shareholders |
09-Jul-2021 10:57:23 AM |
VTL |
40999 NSX Notice of Meeting Other - EGM Restrictions EGM Restrictions and Updated Meeting Procedures |
30-Jun-2021 12:20:07 PM |
VTL |
41999 NSX General Market Disclosure Other - Receipt of finished nutraceutical products VTL receives finished nutraceutical products in US |
15-Jun-2021 9:49:34 AM |
VTL |
40120 NSX Change in Substantial Shareholder - Change in substantial shareholder Change in substantial shareholder notice for VGI Big Bang Pty Ltd |
08-Jun-2021 7:29:01 AM |
VTL |
41999 NSX General Market Disclosure Other - Initiation Report Pitt Street Research issues Initiation Report on Azure Health Technology t/as VGI Health Technology |
08-Jun-2021 7:28:55 AM |
VTLPrice Sensitive |
41999 NSX General Market Disclosure Other - Appointment of cGMP Manufacturer Appointment of cGMP Manufacturer in the US |
07-Jun-2021 9:10:09 AM |
VTL |
40920 NSX Notice of Extraordinary Meeting - Extraordinary General Meeting Extraordinary general meeting to change name of company and approve NSX compliant constitution |
04-Jun-2021 1:35:31 PM |
VTL |
40940 NSX Proxy Form - Proxy Form Proxy form for July EGM |
04-Jun-2021 1:35:42 PM |
VTL |
40399 NSX Issued Capital Other - Application for Quotation of Additional Securities Application for quotation of additional securities following conversion of convertible notes |
02-Jun-2021 9:25:29 AM |
VTL |
40099 NSX Official List Other - Commencement of Trading on the NSX - 28th of May 2021 Commencement of Trading on the NSX - 28th of May 2021 |
28-May-2021 11:31:00 AM |
VTLPrice Sensitive |
40540 NSX Half Yearly Report - Half Yearly Report Interim Report for the half year ended 31 December 2020 |
27-May-2021 2:58:51 PM |
VTL |
40099 NSX Official List Other - Issuers Undertaking Issuers Undertaking |
26-May-2021 10:35:37 AM |
VTL |
40024 NSX Nominated Adviser's Declaration - Nominated Adviser's Declaration Nominated Adviser's Declaration |
26-May-2021 10:34:46 AM |
VTL |
40099 NSX Official List Other - Holding Range Report Holding Range Report |
26-May-2021 10:33:55 AM |
VTL |
40520 NSX Top 20 Shareholders - Top 20 Shareholders Top 20 Shareholders |
26-May-2021 10:33:11 AM |
VTL |
40110 NSX Becoming a Substantial Shareholder - Notice of Substantial Shareholder - Wei Jiang Notice of Substantial Shareholder - Wei Jiang |
26-May-2021 10:32:23 AM |
VTL |
40110 NSX Becoming a Substantial Shareholder - Notice of Substantial Shareholder - VGI Big Bang Pty Ltd - VGI A/c Notice of Substantial Shareholder - VGI Big Bang Pty Ltd - VGI A/c |
26-May-2021 10:31:17 AM |
VTL |
40110 NSX Becoming a Substantial Shareholder - Notice of Substantial Shareholder - Reef Investments Pty Ltd - The Nairn Family A/c Notice of Substantial Shareholder - Reef Investments Pty Ltd - The Nairn Family A/c |
26-May-2021 10:31:02 AM |
VTL |
40110 NSX Becoming a Substantial Shareholder - Notice of Substantial Shareholder - KR & GT Nominees Pty Ltd - The Tong Family A/c Glenn Tong Notice of Substantial Shareholder - KR & GT Nominees Pty Ltd - The Tong Family A/c Glenn Tong |
26-May-2021 10:27:20 AM |
VTL |
40023 NSX Director's Declaration & Undertaking - Director's Declaration - Steven Yu Director's Declaration - Steven Yu |
26-May-2021 10:20:47 AM |
VTL |
40140 NSX Section 205G Notice Initial/Final Director's Interests - Initial Director's Interests - Steven Yu Initial Director's Interests - Steven Yu |
26-May-2021 10:20:21 AM |
VTL |
40023 NSX Director's Declaration & Undertaking - Director's Declaration - Glenn Tong Director's Declaration - Glenn Tong |
26-May-2021 10:19:34 AM |
VTL |
40140 NSX Section 205G Notice Initial/Final Director's Interests - Initial Director's Interests - Glenn Tong Initial Director's Interests - Glenn Tong |
26-May-2021 10:18:59 AM |
VTL |
40023 NSX Director's Declaration & Undertaking - Director's Declaration - Louis Panaccio Director's Declaration - Louis Panaccio |
26-May-2021 10:12:57 AM |
VTL |
40140 NSX Section 205G Notice Initial/Final Director's Interests - Initial Director's Interests - Louis Panaccio Initial Director's Interests - Louis Panaccio |
26-May-2021 10:12:19 AM |
VTLPrice Sensitive |
40510 NSX Annual Report - Annual Report - 30 June 2020 Annual Report - 30 June 2020 |
26-May-2021 10:03:40 AM |
VTLPrice Sensitive |
40510 NSX Annual Report - Annual Report - 30 June 2019 Annual Report - 30 June 2019 |
26-May-2021 10:01:59 AM |
VTL |
40022 NSX Articles of Association/Constitution - Company Constitution Company Constitution |
26-May-2021 10:01:50 AM |
VTL |
40350 NSX Prospectus - Second Replacement Prospectus Second Replacement Prospectus |
26-May-2021 10:01:40 AM |
VTL |
40099 NSX Official List Other - Letter of Application Letter of Application |
26-May-2021 10:01:07 AM |
VTL |
40020 NSX Commencement of Official Quotation - Commencement of Quotation - 11am AEST Friday, 28th of May 2021 Commencement of Quotation - 11am AEST Friday, 28th of May 2021 |
26-May-2021 7:46:57 AM |